You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
XBiotech names director
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
The Market Intelligence Platform
XBiotech Inc. elected Donald MacAdam as a board member.
MacAdam is currently a director of Hammond Power Solutions Inc. and has previously served as CEO of MBVax Bioscience Inc.
Austin, Texas-based XBiotech develops antibodies for treating diseases such as cancer, inflammatory conditions and vascular diseases.